ReviewDrug design, development and therapy2022

Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis.

Manhong Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.